| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,136 |
2025 Half Year Results Announcement
|
28 Aug 2025 8:56AM |
$22.550 |
$21.730 |
fallen by
3.64%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$285 |
Update - Notification of buy-back - AMH
|
28 Aug 2025 8:56AM |
$1.080 |
$0.900 |
fallen by
16.67%
|
|
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$453 |
FY25 Corporate Governance Statement and Appendix 4G
|
28 Aug 2025 8:56AM |
$1.555 |
$1.565 |
risen by
0.64%
|
|
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,136 |
Dividend/Distribution - APE
|
28 Aug 2025 8:56AM |
$22.550 |
$21.730 |
fallen by
3.64%
|
|
| Metallium Limited (MTM) ORDINARY FULLY PAID |
Materials |
$438 |
Exercise of performance rights & share sale for tax planning
|
28 Aug 2025 8:56AM |
$0.795 |
$0.595 |
fallen by
25.16%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,199 |
Investor Presentation & Speech FY25 Results Briefing
|
28 Aug 2025 8:55AM |
$38.090 |
$39.850 |
risen by
4.62%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 results highlight Ramsay Health Care's transformation strategy.
- Focus on expanding procedural capacity and telehealth in Australia.
- Strong performance from Australian and UK hospitals.
- Challenges in Elysium and Ramsay Santé noted.
- 6.5% increase in underlying NPAT growth for the Funding Group.
- Leverage ratios remain within target range.
- Strategic priorities include capital discipline and 'People caring for People' culture.
- Investments in digital and AI for enhanced healthcare delivery.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,199 |
Investor Presentation & Speech FY25 Results Briefing
|
28 Aug 2025 8:55AM |
$38.090 |
$39.850 |
risen by
4.62%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong revenue growth driven by activity growth in Australia and the UK.
- EBIT impacted by lower earnings from Elysium.
- Net financing costs declined due to lower net debt levels post-sale of RSD.
- ROCE reflects flat earnings on higher capital employed.
- Leverage ratio within target range and covenants.
- Solid performance in Australian private hospitals.
- UK hospitals showed improved performance driven by NHS volume.
- Elysium underwent restructuring with a focus on telehealth expansion.
- Ramsay Santé focused on disciplined capital management and strategic options evaluation.
- New leadership structure and strategic initiatives for Australian transformation.
- Continued focus on operational excellence across all regions.
- Introduction of 'Big 5' hospital operational initiatives.
- Improved revenue indexation and operational improvements in private hospitals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Eagers Automotive Limited (APE) ORDINARY FULLY PAID |
Consumer Discretionary |
$6,136 |
2025 Half Yearly Report and Accounts
|
28 Aug 2025 8:55AM |
$22.550 |
$21.730 |
fallen by
3.64%
|
|
APE - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax of $134.2 million for the half year ended June 30, 2025.
- Total revenue from external customers amounted to $6.5 billion.
- Major revenue sources include new vehicles, used vehicles, parts, and services.
- The company's operations are primarily based in Australia and New Zealand.
- Total assets of $5.9 billion and total liabilities of $4.6 billion.
- Equity attributable to owners amounts to $1.35 billion.
- Significant business acquisitions, divestments, and integration costs.
- Strategic focus on growth and profitability.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$453 |
FY25 Full Year Results Investor Presentation
|
28 Aug 2025 8:55AM |
$1.555 |
$1.565 |
risen by
0.64%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax (NPAT) was A$416.8 million.
- Total revenue for FY25 was A$471.2 million.
- Deconsolidation of Funds 2 and 3 improved balance sheet valuation.
- Fair value adjustments contributed significantly to income.
- The portfolio includes over 300 active investments.
- Omni Bridgeway is a global leader in litigation funding.
- The company received high industry recognition in 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$453 |
FY25 Full Year Results Investor Presentation
|
28 Aug 2025 8:55AM |
$1.555 |
$1.565 |
risen by
0.64%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Total statutory income of A$77.4 million, up 43% from FY23.
- NPAT increased to A$18.9 million.
- Employee expenses reduced by 18% to A$28.1 million.
- Total income of A$651.2 million.
- Platform expenses managed at A$84.1 million.
- Assets under management at A$5.2 billion.
- Achieved 2.5x MOIC across 60 full and partial completions.
- Investment portfolio includes over 300 active investments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| South32 Limited (S32) ORDINARY FULLY PAID |
Materials |
$19,785 |
Appendix 4G - Key to Disclosures
|
28 Aug 2025 8:55AM |
$2.910 |
$4.410 |
risen by
51.55%
|
|
| Omni Bridgeway Limited (OBL) ORDINARY FULLY PAID US PROHIBITED |
Financials |
$453 |
FY25 Appendix 4E and Annual Report
|
28 Aug 2025 8:55AM |
$1.555 |
$1.565 |
risen by
0.64%
|
|
OBL - Price-sensitive ASX Announcement
Full Release
Key Points
- Establishment of Fund 9 resulting in a deconsolidation gain.
- Total comprehensive income for the year was $452.2 million.
- Significant proceeds and payments related to litigation investments.
- Financial risk management includes foreign currency risk analysis.
- Changes in equity involve share-based payments and transactions with non-controlling interests.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| South32 Limited (S32) ORDINARY FULLY PAID |
Materials |
$19,785 |
2025 Annual Report
|
28 Aug 2025 8:55AM |
$2.910 |
$4.410 |
risen by
51.55%
|
|
| Emyria Limited (EMD) ORDINARY FULLY PAID |
Health Care |
$40 |
2025 Annual General Meeting - Key Dates
|
28 Aug 2025 8:55AM |
$0.050 |
$0.050 |
fallen by
0%
|
|
| Westgold Resources Limited (WGX) ORDINARY FULLY PAID |
Materials |
$5,301 |
2025 Annual General Meeting - Key Dates
|
28 Aug 2025 8:54AM |
$3.370 |
$5.610 |
risen by
66.47%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,199 |
Financial Results for the Year Ended 30 June 2025
|
28 Aug 2025 8:54AM |
$38.090 |
$39.850 |
risen by
4.62%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Solid performance in Australian and UK hospital businesses.
- Multi-year business transformation underway.
- Improved revenue indexation for FY25 and FY26 in Australia.
- Significant reduction in net profit after tax from continuing operations.
- Fully franked final dividend of 40¢ with a full year dividend of 80¢.
- Ongoing challenges with Elysium and Ramsay Santé.
- Progress on transformation priorities with key executive appointments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$9,199 |
Financial Results for the Year Ended 30 June 2025
|
28 Aug 2025 8:54AM |
$38.090 |
$39.850 |
risen by
4.62%
|
|
RHC - Price-sensitive ASX Announcement
Full Release
Key Points
- Total segment revenue increased by 6.3% to AUD 17,844.6 million.
- EBIT from continuing operations declined by 29.2% to AUD 706.2 million.
- Net profit after tax from continuing operations decreased by 82.4% to AUD 46.3 million.
- Underlying profit after tax rose by 1.7% excluding non-recurring items.
- A non-cash impairment impacted the UK region negatively.
- Fully franked final dividend declared at 40.0¢ per share.
- Dividend Reinvestment Plan suspended indefinitely.
- Focus on optimizing shareholder returns and strategic priorities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$55 |
FY2025 Appendix 4G & Corporate Governance Statement
|
28 Aug 2025 8:54AM |
$0.087 |
$0.180 |
risen by
106.90%
|
|
| Adveritas Limited (AV1) ORDINARY FULLY PAID |
Information Technology |
$80 |
Appendix 4E and 30 June 2025 Annual Financial Statements
|
28 Aug 2025 8:53AM |
$0.160 |
$0.086 |
fallen by
46.25%
|
|
AV1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Adveritas Limited reported a loss of $7,085,752 for the year ended 30 June 2025.
- Revenue primarily came from foreign customers, totaling $7,843,953.
- Cash flow from operations was negative, primarily due to higher payments to suppliers and employees.
- The company raised $8,500,000 through share issues during the fiscal year.
- Net assets increased to $4,382,480, aided by increased share capital.
- The company issued performance rights to key executives, linked to strategic milestones.
- Share-based payments expense increased to $990,096.
- Foreign currency translation adjustments resulted in a positive impact on total comprehensive income.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Investment Management Ltd (CIW) ORDINARY FULLY PAID |
Financials |
$27 |
Update - Notification of buy-back - CIW
|
28 Aug 2025 8:53AM |
$0.390 |
$0.330 |
fallen by
15.38%
|
|
| Stockland (SGP) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$10,432 |
Appendix 3Y - Mr T Gupta
|
28 Aug 2025 8:53AM |
$6.250 |
$4.290 |
fallen by
31.36%
|
|
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$12,529 |
Qantas Group FY25 Results Investor Presentations
|
28 Aug 2025 8:52AM |
$11.110 |
$8.280 |
fallen by
25.47%
|
|
QAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Qantas Group revenue increased by 6% to $9,161 million in FY25.
- Underlying EBIT rose by 7% to $596 million.
- Jetstar Group revenue grew by 16%, with a 55% increase in underlying EBIT.
- Qantas Loyalty achieved a 9% increase in underlying EBIT.
- Project Sunrise and A350 introduction for ultra-long-haul services.
- Significant investments in fleet enhancements and new partnerships.
- Challenges include wage escalation and capacity-related inefficiencies.
- Strategic cost management and planning to mitigate challenges.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lithium Plus Minerals Ltd (LPM) ORDINARY FULLY PAID |
Materials |
$15 |
Moonlight Resources to acquire Clermont Gold Project
|
28 Aug 2025 8:52AM |
$0.078 |
$0.110 |
risen by
41.03%
|
|
LPM - Price-sensitive ASX Announcement
Full Release
Key Points
- Moonlight Resources to acquire Clermont Gold Project from Diatreme Resources.
- Acquisition includes A$3.25 million in Moonlight shares and A$250,000 in cash.
- Moonlight Resources owned 44.7% by Lithium Plus Minerals Ltd.
- Transaction linked to Moonlight's proposed ASX IPO.
- Diatreme to hold between 17.1% and 19.9% stake post-IPO.
- Transaction subject to due diligence and regulatory approvals.
- LPM to continue focusing on its lithium projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diatreme Resources Limited (DRX) ORDINARY FULLY PAID |
Materials |
$80 |
LPM: Moonlight Resources to acquire Clermont Gold Project
|
28 Aug 2025 8:52AM |
$0.020 |
$0.016 |
fallen by
20%
|
|
| Verbrec Limited (VBC) ORDINARY FULLY PAID |
Industrials |
$55 |
FY2025 Appendix 4E - Preliminary Final Report
|
28 Aug 2025 8:52AM |
$0.087 |
$0.180 |
risen by
106.90%
|
|
VBC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 8.3% to $85,617,000.
- Net profit increased by 91.7% to $3,735,000.
- Declared a final dividend of 0.1 cents per share.
- Net tangible assets per share increased by 54.8%.
- No changes in subsidiaries, joint ventures, or control.
- Financial statements audited and comply with Australian standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
